InvestmentMay 13, 2026, 08:11 AM
Whitehawk Therapeutics Secures $87.5M PIPE Financing
AI Summary
Whitehawk Therapeutics announced an $87.5 million private placement equity (PIPE) financing. The company will sell 4,330,866 shares of common stock at $3.92 per share and 17,991,021 pre-funded warrants at $3.9199 per warrant. The financing, which includes participation from existing investors and company insiders, is expected to close on May 14, 2026. Whitehawk intends to use the net proceeds to advance its ADC pipeline and related development activities, extending its cash runway into the second half of 2028.
Key Highlights
- Whitehawk Therapeutics secured $87.5 million in gross proceeds from a PIPE financing.
- The financing includes the sale of 4,330,866 shares of common stock at $3.92 per share.
- It also includes 17,991,021 pre-funded warrants at $3.9199 per warrant.
- Pre-funded warrants have an exercise price of $0.0001 per share.
- Executive officers, directors, and affiliated funds committed to purchase $39.75 million of securities.
- The PIPE financing is expected to close on May 14, 2026.
- Proceeds are expected to extend the company's cash runway into the second half of 2028.